Digestive Diseases and Sciences

, Volume 51, Issue 3, pp 446–453 | Cite as

Prevalence, Sociodemography, and QualitLife of Older Versus Younger Patients with Irritable Bowel Syndrome: A Population-Based Study

  • Anil Minocha
  • William D. Johnson
  • Thomas L. Abell
  • William Chad Wigington
Intestinal Diseases and Irritable Bowel Syndrome


We studied the prevalence as well as the sociodemographic characteristics and QOL of older adults (> 50 years) with irritable bowel syndrome (IBS) among the population at large and compared it to their younger counterparts’. We hypothesized that IBS is less prevalent among older persons and they suffer poorer QOL compared to younger IBS patients. A total of 1000 adults fnine sites, including a medical center, churches, and a blood bank in our metropolitan area (670 African Americans, 320 Caucasians, and 10 others), completed self-administered questionnaires providing sociodemographic information and details regarding bowel habits and associated symptoms for diagnosing the IBS based on Rome II criteria. QOL was assessed by the SF-12 questionnaire. The study database was divided into two groups, younger (< 50 years) and older (≥50 years). The two age groups were similar with respect to gender and household income. Ninety-five of the 1000 participants had IBS, giving a total sample prevalence of 9.5% (< 50 years, 9.9%, vs ≥50 years, 7.6%). The prevalence of IBS was similar in the two groups irrespective of race, sex, marital status, size of household, location of residence (rural versus urban), level of educational status, and household income. Compared to the older group, there was a trend toward a higher prevalence of IBS among divorced subjects (12.7% vs 0%; P = 0.1) and those below poverty level of income (15.3% vs 7.5%; P = 0.09) in the younger subjects. In contrast, older IBS patients were more likely to attend church regularly (32.5% vs 58.8%; P < 0.05). There were no differences in histortraveler’s diarrhea, food intolerance, and drug allergies between the two groups. Health care utilization was similar between the two IBS groups in terms of number of physician visits, use of prescription and alternative medications, and being disabled due to IBS. There was no difference in the overall QOL score means (27.8 vs 29.5; P = NS) or in its general health and physical functioning components. However, older IBS patients had better social functioning (9.1 vs 9.8; P < 0.05). Although in our study IBS occurred less frequently among older adults than among younger patients, the difference is not statistically significant. While IBS affects QOL at all ages, social functioning was actually better on average among older compared to younger IBS patients.

Key Words

epidemiology older adult geriatrics functional gastrointestinal disorders irritable bowel syndrome quality of life 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Olubuyide IO, Olawuyi F, Fasanmade AA: A study of irritable bowel syndrome diagnosed by Manning criteria in an African population. Dig Dis Sci 40(5):983–985, 1995CrossRefPubMedGoogle Scholar
  2. 2.
    Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ: A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome Am J Gastroenterol 95(10):2679–2681, 2000CrossRefGoogle Scholar
  3. 3.
    Saito YA, Schoenfeld P, Locke GR: The epidemiology of irritable bowel syndrome in North America: A systematic review. Am J Gastroenterol 97(8):1910–1915, 2002PubMedGoogle Scholar
  4. 4.
    Boyce Philip M, Talley Nicholas J: Irritable bowel syndrome according to varying diagnostic criteria: Are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 95(11):3176–3183, 2000Google Scholar
  5. 5.
    O’Keefe EA, Talley NJ, et al.: A bowel symptom questionnaire for the elderly. J Gerontol 47(4):M116–M121, 1992PubMedGoogle Scholar
  6. 6.
    Sandler RS: Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 99:409–415, 1990PubMedGoogle Scholar
  7. 7.
    Hungin AP, Whorwell PJ, Tack J, Mearin F: The prevalence, patterns and impact of irritable bowel syndrome: An international survey of 40,000 subjects. Aliment Pharmacol Ther 17(5):643–650, 2003CrossRefPubMedGoogle Scholar
  8. 8.
    Talley NJ, Phillips SF, et al.: Assessment of functional gastrointestinal disease: The Bowel Disease Questionnaire. Mayo Clin Proc 65(11):1456–1479, 1990PubMedGoogle Scholar
  9. 9.
    Talley NJ, Phillips SF, et al.: A patient questionnaire to identify bowel disease. Ann Intern Med 111(8):671–674, 1989PubMedGoogle Scholar
  10. 10.
    Segal I, Hunt JA: The irritable bowel syndrome in the urban South African Negro. South Afr Med J 55:1645–1646, 1975Google Scholar
  11. 11.
    Bommelaer G, Dorval E, Denis P, Czernichow P, Frexinos J, Pelc A, Slama A, El Hasnaoui A: Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria. Gastroenterol Clin Biol 26(12):1118–1123, 2002PubMedGoogle Scholar
  12. 12.
    Li FX, Patten SB, Hilsden RJ, Sutherland LR: Irritable bowel syndrome and health- related QOL: a population-based study in Calgary, Alberta. Can J Gastroenterol 17(4):259–263, 2003PubMedGoogle Scholar
  13. 13.
    O’Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ: Bowel disorders impair functional status and QOL in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci 50(4):M184–M189, 1995PubMedGoogle Scholar
  14. 14.
    Gwee KA, Wee S, Wong ML, Png DJ: The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol 99(5):924–931, 2004CrossRefPubMedGoogle Scholar
  15. 15.
    Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ: A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther 119(11):1217–1224, 2004Google Scholar
  16. 16.
    Locke GR 3rd, Yawn BP, Wollan PC, Melton LJ 3rd, Lydick E, Talley NJ: Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. Aliment Pharmacol Ther 119(9):1025–1031, 2004Google Scholar
  17. 17.
    Talley NJ, O’Keefe EA, Zinsmeister AR, Melton LJ 3rd: Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 102(3):895–901, 1992PubMedGoogle Scholar
  18. 18.
    Kay L: Prevalence, incidence and prognosis of gastrointestinal symptoms in a random sample of an elderly population. Age Ageing 23(2):146–149, 1994PubMedGoogle Scholar
  19. 19.
    Sperber AD, Shvartzman P, Friger M, Fich A: Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterol Motil 17(2):207–211, 2005CrossRefPubMedGoogle Scholar
  20. 20.
    Ehrenpreis ED: Irritable bowel syndrome. 10% to 20% of older adults have symptoms consistent with diagnosis. Geriatrics 60(1):25–28, 2005PubMedGoogle Scholar
  21. 21.
    Bennett G, Talley NJ: Irritable bowel syndrome in the elderly. Best Pract Res Clin Gastroenterol 16(1):63–76, 2002CrossRefPubMedGoogle Scholar
  22. 22.
    Friedel D, Krevsky B: Irritable bowel syndrome in the elderly. Clin Geriatr 8(9):36–47, 2000Google Scholar
  23. 23.
    Drossman DA, et al.: Rome II:The Functional Gastrointestinal Disorders, 2nd ed. McLean, VA, Degnon Associates, 2000Google Scholar
  24. 24.
    Feldman et al.: Sleisenger and Fordtran’s Gastrointestinal and Liver Disease— Pathophysiology/Diagnosis/Management, 7th ed. Philadelphia, PA, Saunders, 2002Google Scholar
  25. 25.
    Snape WJ, et al.: Evidence that abnormal myoelectrical activity produces colonic motor dysfunction in the irritable bowel syndrome. Gut 19:391–395, 1978Google Scholar
  26. 26.
    Latimer P, et al.: Colonic motor and myelctrical activity: a comparative study of normal subjects, psychoneurotic patients and patients with the irritable bowel syndrome. Gastroenterology 80:893–901, 1981PubMedGoogle Scholar
  27. 27.
    Cann PA, Read NW, Brown C, et al.: The irritable bowel syndrome (IBS) relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 24:405–411, 1983PubMedGoogle Scholar
  28. 28.
    Lasser RB, Bond JH, Levitt ND: The role of intestinal gas and functional abdominal pain. N Engl J Med 293:524–526, 1975PubMedGoogle Scholar
  29. 29.
    MacQueen G, Marshall J, Perdue M, Siegel S: Pavlovian conditioning of the rat muscosal mast cells to secrete rat mast cell protease II. Science 243:83–85, 1989PubMedGoogle Scholar
  30. 30.
    Weston AP, Biddle WL, Bhatia PS, Miner PB: Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 38:1590–1595, 1993CrossRefPubMedGoogle Scholar
  31. 31.
    McKendrick MW, Read NW: Irritable bowel syndrome—post salmonella infection. J Infect 29:1–3, 1994CrossRefPubMedGoogle Scholar
  32. 32.
    Rodriguez LA, Ruigomez A: Increased risk of irritable bowel syndrome after bacterial gastroenteritis. BMJ 318:565–566, 1999PubMedGoogle Scholar
  33. 33.
    Edwards CA, Baxter J, Brown S, et al: Effect of bile acids on anorectal function in humans. Gut 30:383–386, 1989PubMedGoogle Scholar
  34. 34.
    Mayer EA, Gebhart GF: Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107:271–293, 1994PubMedGoogle Scholar
  35. 35.
    Lee CT, Chuang TY, Lu CL, Chen CY: Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: a hospital-based Oriental study. Dig Dis Sci 43:1794–1799, 1998CrossRefPubMedGoogle Scholar
  36. 36.
    Aggarwal A, Cutts TF, Abell TL, et al.: Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterology 106:945–950, 1994PubMedGoogle Scholar
  37. 37.
    El-Serag HB: Impact of irritable bowel syndrome:prevalence and effect on health-related QOL. Rev Gastroenterol Disord 3 (Suppl 2):S3–S11, 2003PubMedGoogle Scholar
  38. 38.
    Drossman DA, Li Z, Andruzzi E, et al.: U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 38(9):1569–1580, 1993CrossRefPubMedGoogle Scholar
  39. 39.
    Levy RL, Whitehead WE, Walker LS, Von Korff M, Feld AD, Garner M, Christie D: Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol 99(12):2442–2451, 2004CrossRefPubMedGoogle Scholar
  40. 40.
    Locke GR 3rd, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ 3rd: Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 75(9):907–912, 2000PubMedGoogle Scholar
  41. 41.
    Zar S, Kumar D, Benson MJ: Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther 15(4):439–449, 2001CrossRefPubMedGoogle Scholar
  42. 42.
    Neal KR, Hebden J, Spiller R: Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome:postal survey of patients. BMJ 314(7083):779–782, 1997PubMedGoogle Scholar
  43. 43.
    Jones R, Lydeard S: Irritable bowel syndrome in the general population. BMJ 304(6819):87–90, 1992PubMedGoogle Scholar
  44. 44.
    Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C: Health-related QOL associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 24(4):675–689, discussion 674, 2002CrossRefPubMedGoogle Scholar
  45. 45.
    Halder SL, Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd: Impact of functional gastrointestinal disorders on health-related QOL: a population-based case-control study. Aliment Pharmacol Ther 19(2):233–242, 2004CrossRefPubMedGoogle Scholar
  46. 46.
    El-Serag HB, Olden K, Bjorkman D: Health-related QOL among persons with irritable bowel syndrome:a systematic review. Aliment Pharmacol Ther 16(6):1171–1185, 2002CrossRefPubMedGoogle Scholar
  47. 47.
    Wigington WC, Johnson WD, Minocha A: Epidemiology of irritable bowel syndrome among African Americans compared to Caucasians: A population based study. Clin Gastroenterol Hepatol 3(7):647–653, 2005CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • Anil Minocha
    • 1
    • 3
  • William D. Johnson
    • 2
  • Thomas L. Abell
    • 1
  • William Chad Wigington
    • 1
  1. 1.Department of Medicine, Division of Digestive DiseasesUniversity of Mississippi Medical CenterJacksonUSA
  2. 2.Department of Preventive Medicine, Division of BiostatisticsUniversity of Mississippi Medical CenterJacksonUSA
  3. 3.Division of Digestive DiseasesUniversity of Mississippi Medical CenterJacksonUSA

Personalised recommendations